Literature DB >> 33017204

Seroprevalence for vaccine-preventable diseases among Italian healthcare workers.

Luca Coppeta1, Iacopo D'Alessandro1, Antonio Pietroiusti2, Giuseppina Somma1, Ottavia Balbi1, Ilaria Iannuzzi1, Andrea Magrini2.   

Abstract

Healthcare workers (HCWs) have an increased risk to be exposed to infectious diseases compared to the general population. For this reason, according to the National Immunization and Prevention Plan, all HCWs should have demonstrable evidence of immunity to measles, mumps, rubella, varicella and Hepatitis B. Earlier studies have already shown that a large percentage of Italian operators lacked immune protection for one or more of those pathogens.The aim of this study was to evaluate the immunization status for vaccine-preventable diseases of HCWs in a large Italian teaching hospital. We retrospectively evaluated clinical records and serological data of HCWs who followed the occupational health surveillance program between January 1 and December 31 2019. We reviewed the clinical records of 1,017 HCWs: 393 males and 624 females with a median age of 35.69 y (range: 19-67). Protective IgG antibody values were documented in the 88.0%, 75.7%, 90.3%, 87.4% and 85.7% of the HCWs screened, respectively, against measles, mumps, rubella, varicella and Hepatitis B. Age was significantly related to serological protection against measles, mumps and varicella but was not significantly related to protective IgG levels for rubella and HBV.Female gender was significantly related to a higher protection rate against Hepatitis B (87.8 vs 82.4%; p < .01) whereas males were significantly more protected against varicella (92-4 vs 84.1%; p < .01).Our study shows suboptimal levels of protection among Italian HCWs and a consequent increased risk of infection for them and their patients. Public health policies should be focused on improving preventive strategies, including serological screening and workplace vaccination of nonimmune individuals.

Entities:  

Keywords:  healthcare workers; measles; occupational epidemiology

Mesh:

Substances:

Year:  2020        PMID: 33017204      PMCID: PMC8078750          DOI: 10.1080/21645515.2020.1818523

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  40 in total

1.  Measles among healthcare workers in a teaching hospital in central Italy.

Authors:  Pamela Barbadoro; Anna Marigliano; Elena Di Tondo; Maria De Paolis; Enrica Martini; Emilia Prospero; Marcello Mario D'Errico
Journal:  J Occup Health       Date:  2012-05-18       Impact factor: 2.708

Review 2.  Susceptibility to vaccine-preventable diseases and vaccination adherence among healthcare workers in Italy: A cross-sectional survey at a regional acute-care university hospital and a systematic review.

Authors:  Umberto Leone Roberti Maggiore; Carolina Scala; Alessandra Toletone; Nicoletta Debarbieri; Mauro Perria; Beatrice D'Amico; Alfredo Montecucco; Mariano Martini; Guglielmo Dini; Paolo Durando
Journal:  Hum Vaccin Immunother       Date:  2016-12-07       Impact factor: 3.452

3.  HBV seroprevalence after 25 years of universal mass vaccination and management of non-responders to the anti-Hepatitis B vaccine: An Italian study among medical students.

Authors:  Francesco P Bianchi; Maria S Gallone; Maria F Gallone; Angela M V Larocca; Luigi Vimercati; Michele Quarto; Silvio Tafuri
Journal:  J Viral Hepat       Date:  2018-10-17       Impact factor: 3.728

Review 4.  Vaccine hesitancy: an overview.

Authors:  Eve Dubé; Caroline Laberge; Maryse Guay; Paul Bramadat; Réal Roy; Julie Bettinger
Journal:  Hum Vaccin Immunother       Date:  2013-04-12       Impact factor: 3.452

5.  Cost-effectiveness of workplace vaccination against measles.

Authors:  Luca Coppeta; Luca Morucci; Antonio Pietroiusti; Andrea Magrini
Journal:  Hum Vaccin Immunother       Date:  2019-07-24       Impact factor: 3.452

6.  Persistence of immunity to live attenuated varicella vaccine in healthy adults.

Authors:  Krow Ampofo; Lisa Saiman; Philip LaRussa; Sharon Steinberg; Paula Annunziato; Anne Gershon
Journal:  Clin Infect Dis       Date:  2002-02-04       Impact factor: 9.079

7.  Waning antibody levels and avidity: implications for MMR vaccine-induced protection.

Authors:  Mia Kontio; Sari Jokinen; Mikko Paunio; Heikki Peltola; Irja Davidkin
Journal:  J Infect Dis       Date:  2012-09-10       Impact factor: 5.226

8.  [Nosocomial varicella: study of an epidemic outbreak among immunosuppressed patients].

Authors:  A Antela; J Fortún; E Navas; J M Hermida; R Fernández-Muñoz; A Guerrero
Journal:  Enferm Infecc Microbiol Clin       Date:  1991 Jun-Jul       Impact factor: 1.731

9.  Vaccination coverage in healthcare workers: a multicenter cross-sectional study in Italy.

Authors:  C Genovese; I A M Picerno; G Trimarchi; G Cannavò; G Egitto; B Cosenza; V Merlina; G Icardi; D Panatto; D Amicizia; A Orsi; C Colosio; C Marsili; C Lari; M A R Palamara; F Vitale; A Casuccio; C Costantino; A Azara; P Castiglia; A Bianco; A Currà; G Gabutti; A Stefanati; F Sandri; C Florescu; M Marranzano; G Giorgianni; V Fiore; A Platania; I Torre; A Cappuccio; A Guillari; L Fabiani; A R Giuliani; A Appetiti; V LA Fauci; A Squeri; R Ragusa; R Squeri
Journal:  J Prev Med Hyg       Date:  2019-03-29

10.  Immunity to rubella: an Italian retrospective cohort study.

Authors:  Francesco Paolo Bianchi; Sara De Nitto; Pasquale Stefanizzi; Angela Maria Vittoria Larocca; Cinzia Annatea Germinario; Silvio Tafuri
Journal:  BMC Public Health       Date:  2019-11-08       Impact factor: 3.295

View more
  4 in total

1.  Long -term persistence of antibodies against varicella in fully immunized healthcare workers: an Italian retrospective cohort study.

Authors:  Francesco Paolo Bianchi; Silvio Tafuri; Angela Maria Vittoria Larocca; Cinzia Annatea Germinario; Pasquale Stefanizzi
Journal:  BMC Infect Dis       Date:  2021-05-25       Impact factor: 3.090

2.  Prevalence and management of rubella susceptibility in healthcare workers in Italy: A systematic review and meta-analysis.

Authors:  Francesco Paolo Bianchi; Pasquale Stefanizzi; Giusy Diella; Andrea Martinelli; Antonio Di Lorenzo; Maria Serena Gallone; Silvio Tafuri
Journal:  Vaccine X       Date:  2022-08-07

3.  Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG.

Authors:  Kirsten Alexandra Eberhardt; Felix Dewald; Eva Heger; Lutz Gieselmann; Kanika Vanshylla; Maike Wirtz; Franziska Kleipass; Wibke Johannis; Philipp Schommers; Henning Gruell; Karl August Brensing; Roman-Ulrich Müller; Max Augustin; Clara Lehmann; Manuel Koch; Florian Klein; Veronica Di Cristanziano
Journal:  Microorganisms       Date:  2021-03-31

4.  Evaluation of Immunity for Mumps among Vaccinated Medical Students.

Authors:  Cristiana Ferrari; Marco Trabucco Aurilio; Andrea Mazza; Antonio Pietroiusti; Andrea Magrini; Ottavia Balbi; Matteo Bolcato; Luca Coppeta
Journal:  Vaccines (Basel)       Date:  2021-06-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.